Scarica l'app Stockscreener
4.78
2.65%
-0.13
Dopo l'orario di chiusura:
4.72
-0.06
-1.26%
Precedente Chiudi:
$4.91
Aprire:
$4.85
Volume 24 ore:
97,611
Relative Volume:
0.25
Capitalizzazione di mercato:
$39.87M
Reddito:
-
Utile/perdita netta:
$-11.46M
Rapporto P/E:
-0.3414
EPS:
-14
Flusso di cassa netto:
$-24.56M
1 W Prestazione:
+1.06%
1M Prestazione:
-19.46%
6M Prestazione:
+95.10%
1 anno Prestazione:
-0.20%
Intervallo 1D:
$4.76
$5.0164
Intervallo di 1 settimana:
$4.70
$5.22
Portata 52W:
$1.20
$12.15
Evaxion A S Adr Stock (EVAX) Company Profile
Confronta EVAX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EVAX
Evaxion A S Adr
|
4.78 | 40.95M | 0 | -11.46M | -24.56M | -14.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
453.74 | 116.65B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
773.94 | 82.03B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.25 | 52.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
837.90 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
174.09 | 37.61B | 447.02M | -1.18B | -906.14M | -6.1812 |
Evaxion A S Adr Stock (EVAX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-04-02 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2024-02-12 | Iniziato | H.C. Wainwright | Buy |
Evaxion A S Adr Borsa (EVAX) Ultime notizie
Evaxion Seeks New Partner For Gonorrhea Vaccine After Merck Opts Out - Sahm
Evaxion Seeks New Partner For Gonorrhea Vaccine After Merck Opts Out - Benzinga
European Firms Make Gains On US Markets As ADR Index Rises - Finimize
European ADRs Edge Higher Despite Mixed Stock Moves - Finimize
Evaxion Biotech Reports Strong Q3 2025 Results - MSN
Brokerages Set Evaxion A/S – Sponsored ADR (NASDAQ:EVAX) Price Target at $12.33 - Defense World
European ADRs Edge Up With Gains Led By Evaxion - Finimize
Evaxion Biotech’s Earnings Call Highlights Strategic Growth - TipRanks
Analysts Set Evaxion A/S – Sponsored ADR (NASDAQ:EVAX) PT at $12.33 - Defense World
European Biotech Stocks Outperformed As Broader Market Dipped - Finimize
European ADRs Barely Budge While Gainers And Losers Trade Places - Finimize
Evaxion A/S (NASDAQ:EVAX) Given Buy Rating at HC Wainwright - Defense World
European ADRs Edge Higher As Healthcare Leads Gains - Finimize
Take off with Evaxion A/S ADR (EVAX): Get ready for trading - setenews.com
Evaxion A/S – Sponsored ADR (NASDAQ:EVAX) Sees Large Growth in Short Interest - Defense World
Evaxion (NASDAQ:EVAX) Stock Rockets After AI-Powered Cancer Vaccine Breakthrough - ts2.tech
Nothing is Better Than Connexa Sports Technologies Inc (YYAI) stock at the moment - Setenews
Biotech Stocks Lead European ADRs Higher On Wall Street - Finimize
European Equities Traded in the US as American Depositary Fall Sharply in Tuesday Trading - MSN
European Pharma And Biotech Companies Led ADR Gains In The US - Finimize
Evaxion Biotech price target raised to $16 from $14 at H.C. Wainwright - MSN
Analysts Are Bullish on Top Healthcare Stocks: Evaxion Biotech (EVAX), Azitra Inc (AZTR) - The Globe and Mail
Taking on analysts’ expectations and winning: Aditxt Inc (ADTX) - Setenews
Evaxion A S Adr Azioni (EVAX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.23%
0.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):